Trump administration weighs temporary sale of some restricted peptides
Two people familiar with the matter say federal health officials are drafting new rules for the products while interim access is allowed.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 7 23:38 ETSource: The Washington Post
The wire
- 01The Washington Post reports the administration is crafting plans permitting temporary sale of certain previously restricted peptides while regulations are written, per two people speaking anonymously.
- 02Compounders, telehealth prescribers and clinics working with peptides the FDA has restricted would face a changed enforcement posture if the plan proceeds.
- 03No agency document, peptide list or timeline has been made public; the account rests on anonymous sources describing private deliberations.
From the source
Read at washingtonpost.comTrump administration paving way for temporary sale of some unapproved peptides
The Trump administration is crafting plans that would allow the temporary sale of certain previously restricted peptides as federal health officials hammer out new regulations around the controversial products, according to two people familiar with the matter who spoke on the condition of anonymity to share private details.
